{
"info": {
"nct_id": "NCT00674973",
"official_title": "A Phase II Biomarker Identification Trial for Erlotinib (Tarceva®) in Patients With Advanced Pancreatic Carcinoma",
"inclusion_criteria": "* adult patients, >=18 years of age;\n* histologically or cytologically documented locally advanced-unresectable or metastatic pancreatic cancer;\n* measurable disease according to RECIST;\n* failure of at least one prior chemotherapy regimen, or who are deemed unsuitable for chemotherapy;\n* ECOG performance status of 0-2.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* local or locally advanced-resectable pancreatic cancer;\n* any other malignancies within last 5 years, except for adequately treated cancer in situ of the cervix, or basal or squamous cell skin cancer;\n* major surgery within 2 weeks prior to randomization.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* adult patients, >=18 years of age;",
"criterions": [
{
"exact_snippets": "adult patients, >=18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* histologically or cytologically documented locally advanced-unresectable or metastatic pancreatic cancer;",
"criterions": [
{
"exact_snippets": "histologically or cytologically documented",
"criterion": "documentation method",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "locally advanced-unresectable or metastatic pancreatic cancer",
"criterion": "pancreatic cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced-unresectable",
"metastatic"
]
}
]
}
]
},
{
"line": "* measurable disease according to RECIST;",
"criterions": [
{
"exact_snippets": "measurable disease according to RECIST",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "standard",
"expected_value": "RECIST"
}
]
}
]
},
{
"line": "* failure of at least one prior chemotherapy regimen, or who are deemed unsuitable for chemotherapy;",
"criterions": [
{
"exact_snippets": "failure of at least one prior chemotherapy regimen",
"criterion": "prior chemotherapy regimen",
"requirements": [
{
"requirement_type": "failure",
"expected_value": true
}
]
},
{
"exact_snippets": "deemed unsuitable for chemotherapy",
"criterion": "suitability for chemotherapy",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": false
}
]
}
]
},
{
"line": "* ECOG performance status of 0-2.",
"criterions": [
{
"exact_snippets": "ECOG performance status of 0-2.",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* local or locally advanced-resectable pancreatic cancer;",
"criterions": [
{
"exact_snippets": "local or locally advanced-resectable pancreatic cancer",
"criterion": "pancreatic cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"local",
"locally advanced-resectable"
]
}
]
}
]
},
{
"line": "* any other malignancies within last 5 years, except for adequately treated cancer in situ of the cervix, or basal or squamous cell skin cancer;",
"criterions": [
{
"exact_snippets": "any other malignancies within last 5 years",
"criterion": "other malignancies",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
]
},
{
"exact_snippets": "adequately treated cancer in situ of the cervix",
"criterion": "cancer in situ of the cervix",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
]
},
{
"exact_snippets": "basal or squamous cell skin cancer",
"criterion": "basal or squamous cell skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* major surgery within 2 weeks prior to randomization.",
"criterions": [
{
"exact_snippets": "major surgery within 2 weeks prior to randomization",
"criterion": "major surgery",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "weeks"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}